Literature DB >> 22621944

Development and evaluation of a multiplex enzyme-linked immunosorbent assay for the detection of antibodies to bovine respiratory diseases on the Meso Scale Discovery platform.

Jo Mayers1, Jason Sawyer.   

Abstract

A multiplex enzyme-linked immunosorbent assay (ELISA) to detect antibodies to Bovine viral diarrhea virus (BVDV), Bovine herpesvirus 1 (BHV-1), Bovine parainfluenza virus 3 (BPV-3), and Bovine respiratory syncytial virus (BRSV) was developed on the commercially available Meso Scale Discovery (MSD) platform. The multiplex ELISA used the same antigens (relatively crude lysates of cultured virus) that are used in the current in-house separate ELISAs. Testing a panel of field samples demonstrated the multiplex assay could simultaneously detect the presence of several antibodies in a single assay and that there was good agreement between the multiplex ELISA and the in-house ELISAs. The use of a multiplex ELISA could offer significant benefits for routine serological testing through reduced staff time, reduced reagent cost, and streamlined laboratory operation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621944     DOI: 10.1177/1040638712446506

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Validation of a Commercial Indirect ELISA Kit for the Detection of Bovine alphaherpesvirus1 (BoHV-1)-Specific Glycoprotein E Antibodies in Bulk Milk Samples of Dairy Cows.

Authors:  Cecilia Righi; Carmen Iscaro; Laura Ferroni; Sergio Rosati; Claudia Pellegrini; Chiara Nogarol; Elisabetta Rossi; Annalisa Dettori; Francesco Feliziani; Stefano Petrini
Journal:  Vet Sci       Date:  2022-06-22

2.  A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.

Authors:  Elisabetta Casarin; Laura Lucchese; Santina Grazioli; Sonia Facchin; Nicola Realdon; Emiliana Brocchi; Margherita Morpurgo; Stefano Nardelli
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.